| __timestamp | Catalyst Pharmaceuticals, Inc. | PTC Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4473654 | 44820000 |
| Thursday, January 1, 2015 | 8597010 | 82080000 |
| Friday, January 1, 2016 | 7910260 | 97130000 |
| Sunday, January 1, 2017 | 7304399 | 121271000 |
| Monday, January 1, 2018 | 15875961 | 153548000 |
| Tuesday, January 1, 2019 | 36881187 | 202541000 |
| Wednesday, January 1, 2020 | 44233754 | 245164000 |
| Friday, January 1, 2021 | 49628000 | 285773000 |
| Saturday, January 1, 2022 | 58183000 | 325998000 |
| Sunday, January 1, 2023 | 133710000 | 332540000 |
Unlocking the unknown
In the competitive landscape of biotechnology, effective cost management is crucial. Over the past decade, PTC Therapeutics, Inc. and Catalyst Pharmaceuticals, Inc. have demonstrated contrasting strategies in managing their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, PTC Therapeutics saw a staggering 643% increase in SG&A expenses, peaking in 2023. This reflects their aggressive expansion and investment in operational infrastructure. In contrast, Catalyst Pharmaceuticals experienced a more moderate 2,889% rise, indicating a strategic yet cautious approach to scaling operations. Notably, 2023 marked a significant year for both companies, with Catalyst's expenses surging to 133.71 million, while PTC's reached 332.54 million. These trends underscore the dynamic nature of financial management in the biotech sector, where balancing growth and cost efficiency remains a pivotal challenge.
Comparing SG&A Expenses: AstraZeneca PLC vs PTC Therapeutics, Inc. Trends and Insights
SG&A Efficiency Analysis: Comparing Zoetis Inc. and PTC Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Alnylam Pharmaceuticals, Inc. or PTC Therapeutics, Inc.
Breaking Down SG&A Expenses: Viatris Inc. vs PTC Therapeutics, Inc.
Sarepta Therapeutics, Inc. vs Catalyst Pharmaceuticals, Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Ascendis Pharma A/S and PTC Therapeutics, Inc.
Ionis Pharmaceuticals, Inc. or Catalyst Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing PTC Therapeutics, Inc. and Amicus Therapeutics, Inc.
Comparing SG&A Expenses: PTC Therapeutics, Inc. vs Taro Pharmaceutical Industries Ltd. Trends and Insights
Breaking Down SG&A Expenses: PTC Therapeutics, Inc. vs MiMedx Group, Inc.
Comparing SG&A Expenses: Catalyst Pharmaceuticals, Inc. vs Galapagos NV Trends and Insights
Comparing SG&A Expenses: Catalyst Pharmaceuticals, Inc. vs Xencor, Inc. Trends and Insights